Karissa Cryer, DO
Obstetrics & Gynecology · Sherman, TXNPI 1740604206
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (47.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 67.7% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $10,823 and has fallen 95.3% since, to $508 in 2025. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 109 payments — averaging $117.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- Axonics, Inc.$3K
- Astellas Pharma US Inc$397
- AbbVie$358
- Radius Health, Inc.$159
- Amgen$117
- plus $418 from 13 others
What the payments were for
- Travel & lodging$3,26926%
- Food & beverage$3,37626%
- Education$6,10048%
- Gifts$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 27 | $8,638 |
| Axonics, Inc. | 35 | $2,668 |
| Astellas Pharma US Inc | 12 | $397 |
| AbbVie | 8 | $358 |
| Radius Health, Inc. | 4 | $159 |
| Amgen | 2 | $117 |
| Exeltis, USA Inc. | 4 | $62 |
| Organon | 2 | $52 |
| Davol Inc. | 2 | $46 |
| Molnlycke Health Care US, LLC | 2 | $39 |
| Almatica Pharma LLC | 2 | $34 |
| Coopersurgical, Inc. | 1 | $34 |
| Hologic Sales And Service, LLC | 1 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $29 |
| Johnson & Johnson | 1 | $27 |
| Alvogen Inc | 1 | $19 |
| Smith+Nephew | 1 | $18 |
| Minerva Surgical, Inc | 1 | $14 |
| Mayne Pharma Commercial LLC | 2 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$6,000
- Da Vinci Surgical System$2,309
- Axonics$1,794
- Bulkamid$1,020
- Orilissa$125
- Veozah$125
- Tymlos$100
How this compares
$12,755 in reported general payments places this provider in the 90th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 42 | $13,336 |
| Estradiol | 159 | $11,058 |
| Solifenacin Succinate | 69 | $1,483 |
| Clobetasol EmollientClobetasol Propionate/Emoll | 26 | $1,283 |
| ProgesteroneProgesterone, Micronized | 12 | $533 |
| Testosterone Cypionate | 14 | $264 |
| Paroxetine Hcl | 11 | $128 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Sherman
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.